Last reviewed · How we verify

NCT05276050

Circuitry-Guided Smoking Cessation in Schizophrenia (UH3)

Recruiting now NA Last updated 12 January 2026
What this trial tests

NA trial testing active F8-coil delivered rTMS in Smoking Cessation in 50 participants. Currently enrolling.

Timeline
1 June 2022
Primary endpoint
28 July 2026
30 January 2027

Quick facts

Lead sponsorThe University of Texas Health Science Center, Houston
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment50
Start date1 June 2022
Primary completion28 July 2026
Estimated completion30 January 2027
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

The University of Texas Health Science Center, Houston

Who can join

Adults 22 to 65, any sex, with Smoking Cessation or Nicotine Addiction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients with schizophrenia spectrum disorder (SSD) will be exposed to active repetitive transcranial magnetic stimulation (rTMS) from F8 coil or active rTMS from H coil for smoking cessation. Smoking and brain functional connectivity changes will be assessed at baseline, different stages of rTMS and/or follow-ups.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Smoking Cessation

Currently open trials in the same condition.

Other The University of Texas Health Science Center, Houston trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05276050.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing